Related Experiment Video

Updated: Jul 15, 2025

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.9K

Transcription Factor Zbtb20 as a Regulator of Malignancy and Its Practical Applications

Dimo Stoyanov1, George S Stoyanov2, Martin N Ivanov1,3

  • 1Department of Anatomy and Cell Biology, Medical University of Varna, 9000 Varna, Bulgaria.

International Journal of Molecular Sciences
|September 28, 2023
PubMed

Insights

Zinc finger and BTB domain-containing protein 20 (Zbtb20) is a transcription factor involved in neural development. Zbtb20 promotes cancer progression and may serve as a diagnostic marker in hepatocellular carcinoma.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Developmental Biology

Background:

  • Zbtb20 (zinc finger and BTB domain-containing protein 20) is a transcription factor.
  • It plays a role in normal neural development and tissue-specific proliferation and differentiation.
  • Recent studies highlight its involvement in various malignant tumors.

Purpose of the Study:

  • To review the current data connecting Zbtb20 with malignant tumors.
  • To summarize the role of Zbtb20 in tumor biology, particularly in hepatocellular carcinoma.

Main Methods:

  • Literature review of existing studies on Zbtb20 and cancer.
  • Analysis of Zbtb20's functions in proliferation, migration, and apoptosis resistance.
  • Examination of Zbtb20's role as a potential biomarker in hepatocellular carcinoma.

Main Results:

  • Zbtb20 enhances proliferation and migration while conferring resistance to apoptosis in multiple cancers.
  • Its role is well-documented in hepatocellular carcinoma, where it acts as a potential immunohistochemical marker.
  • Zbtb20 is implicated in non-small-cell lung carcinoma, gastric adenocarcinoma, glioblastoma multiforme, breast cancer, and acute myeloid leukemia.

Conclusions:

  • Zbtb20 is a significant factor in the progression of various malignant tumors.
  • Its potential as a tumor marker and in patient screening warrants further investigation, especially in hepatocellular carcinoma.
Keywords:
Zbtb20hepatocellular carcinomamalignant tumors

More Related Videos

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

2.8K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

798

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
76.0K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K